{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:19:53Z","timestamp":1771373993230,"version":"3.50.1"},"reference-count":35,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:00:00Z","timestamp":1708732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research B","award":["21H03012"],"award-info":[{"award-number":["21H03012"]}]},{"name":"Grant-in-Aid for Scientific Research B","award":["21H04145"],"award-info":[{"award-number":["21H04145"]}]},{"name":"Grant-in-Aid for Scientific Research B","award":["22H04265"],"award-info":[{"award-number":["22H04265"]}]},{"name":"Grant-in-Aid for Scientific Research B","award":["23H05238"],"award-info":[{"award-number":["23H05238"]}]},{"name":"Grants-in-Aid for Encouragement of Scientists","award":["21H03012"],"award-info":[{"award-number":["21H03012"]}]},{"name":"Grants-in-Aid for Encouragement of Scientists","award":["21H04145"],"award-info":[{"award-number":["21H04145"]}]},{"name":"Grants-in-Aid for Encouragement of Scientists","award":["22H04265"],"award-info":[{"award-number":["22H04265"]}]},{"name":"Grants-in-Aid for Encouragement of Scientists","award":["23H05238"],"award-info":[{"award-number":["23H05238"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer in dogs has increased in recent years and is a leading cause of death. We have developed a retroviral replicating vector (RRV) that specifically targets cancer cells for infection and replication. RRV carrying a suicide gene induced synchronized killing of cancer cells when administered with a prodrug after infection. In this study, we evaluated two distinct RRVs derived from amphotropic murine leukemia virus (AMLV) and gibbon ape leukemia virus (GALV) in canine tumor models both in vitro and in vivo. Despite low infection rates in normal canine cells, both RRVs efficiently infected and replicated within all the canine tumor cells tested. The efficient intratumoral spread of the RRVs after their intratumoral injection was also demonstrated in nude mouse models of subcutaneous canine tumor xenografts. When both RRVs encoded a yeast cytosine deaminase suicide gene, which converts the prodrug 5-fluorocytosine (5-FC) to the active drug 5-fluorouracil, they caused tumor-cell-specific 5-FC-induced killing of the canine tumor cells in vitro. Furthermore, in the AZACF- and AZACH-cell subcutaneous tumor xenograft models, both RRVs exerted significant antitumor effects. These results suggest that RRV-mediated suicide gene therapy is a novel therapeutic approach to canine cancers.<\/jats:p>","DOI":"10.3390\/ijms25052657","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T06:50:23Z","timestamp":1708930223000},"page":"2657","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted Suicide Gene Therapy with Retroviral Replicating Vectors for Experimental Canine Cancers"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9697-1182","authenticated-orcid":false,"given":"Emiko","family":"Sonoda-Fukuda","sequence":"first","affiliation":[{"name":"Laboratory of Molecular and Genetic Therapeutics, Institute of Advanced Medical Science, Hyogo Medical University, Nishinomiya 663-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Genetic Therapeutics, Institute of Advanced Medical Science, Hyogo Medical University, Nishinomiya 663-8501, Japan"},{"name":"Departments of Biomedical Chemistry, School of Science and Technology, Kwansei Gakuin University, Sanda 669-1330, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Genetic Therapeutics, Institute of Advanced Medical Science, Hyogo Medical University, Nishinomiya 663-8501, Japan"},{"name":"Departments of Biomedical Chemistry, School of Science and Technology, Kwansei Gakuin University, Sanda 669-1330, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0915-4829","authenticated-orcid":false,"given":"Shunsuke","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Radiology, Graduate School of Veterinary Science, Osaka Metropolitan University, Izumisano 598-8531, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-4433","authenticated-orcid":false,"given":"Toru","family":"Takarada","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Genetic Therapeutics, Institute of Advanced Medical Science, Hyogo Medical University, Nishinomiya 663-8501, Japan"},{"name":"Laboratory of Functional Molecular Chemistry, Kobe Pharmaceutical University, Kobe 658-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6069-9082","authenticated-orcid":false,"given":"Noriyuki","family":"Kasahara","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and Radiation Oncology, University of California, San Francisco, CA 94143, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7384-4835","authenticated-orcid":false,"given":"Shuji","family":"Kubo","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Genetic Therapeutics, Institute of Advanced Medical Science, Hyogo Medical University, Nishinomiya 663-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,24]]},"reference":[{"key":"ref_1","first-page":"51","article-title":"Spontaneously occurring canine cancer as a relevant animal model for developing novel treatments for human cancers","volume":"3","author":"Mizuno","year":"2021","journal-title":"Transl. Regul. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sanchez, D., Cesarman-Maus, G., Amador-Molina, A., and Lizano, M. (2018). Oncolytic Viruses for Canine Cancer Treatment. Cancers, 10.","DOI":"10.3390\/cancers10110404"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3389\/fonc.2019.01257","article-title":"Canine Cancer: Strategies in Experimental Therapeutics","volume":"9","author":"Thamm","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1308890","DOI":"10.3389\/fimmu.2023.1308890","article-title":"Oncolytic virotherapy in cancer treatment: Challenges and optimization prospects","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Volovat, S.R., Scripcariu, D.V., Vasilache, I.A., Stolniceanu, C.R., Volovat, C., Augustin, I.G., Volovat, C.C., Ostafe, M.R., Andreea-Voichi\u021ba, S.G., and Bejusca-Vieriu, T. (2024). Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021180"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-21-3324","article-title":"Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies","volume":"28","author":"Kleijn","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1245\/s10434-016-5286-0","article-title":"Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial","volume":"23","author":"Andtbacka","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mt.2008.240","article-title":"A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer","volume":"17","author":"Fong","year":"2009","journal-title":"Mol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: A phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1158\/1078-0432.CCR-23-0229","article-title":"Comprehensive Single-Cell Immune Profiling Defines the Patient Multiple Myeloma Microenvironment Following Oncolytic Virus Therapy in a Phase Ib Trial","volume":"29","author":"Nawrocki","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1158\/0008-5472.CAN-17-3754","article-title":"Remission of Spontaneous Canine Tumors after Systemic Cellular Viroimmunotherapy","volume":"78","author":"Cejalvo","year":"2018","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/vco.12361","article-title":"Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours","volume":"16","author":"Hwang","year":"2018","journal-title":"Vet. Comp. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fvets.2018.00116","article-title":"Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study)","volume":"5","author":"Ilyinskaya","year":"2018","journal-title":"Front. Vet. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1016\/j.ymthe.2005.07.340","article-title":"The Effects of Intratumoral Injection of a Replicating Morbillivirus in a Canine Model of Naturally Occurring Lymphoma","volume":"11","author":"Henson","year":"2005","journal-title":"Mol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sanchez, D., Pelayo, R., Medina, L.A., Vadillo, E., Sanchez, R., Nunez, L., Cesarman-Maus, G., and Sarmiento-Silva, R.E. (2015). Newcastle Disease Virus: Potential Therapeutic Application for Human and Canine Lymphoma. Viruses, 8.","DOI":"10.3390\/v8010003"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e002086","DOI":"10.1136\/jitc-2020-002086","article-title":"Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy","volume":"9","author":"Shin","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/14712598.2021.1902982","article-title":"Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer","volume":"21","author":"Collins","year":"2021","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/cgt.2013.67","article-title":"Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus","volume":"20","author":"Kubo","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-12-386509-0.00011-9","article-title":"Retroviral replicating vectors in cancer","volume":"507","author":"Logg","year":"2012","journal-title":"Methods Enzym."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41417-018-0020-7","article-title":"Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer","volume":"25","author":"Inoko","year":"2018","journal-title":"Cancer Gene Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kushiya, H., Hiraoka, K., Suzuki, T., Inoko, K., Inagaki, A., Niwa, H., Sasaki, K., Nakamura, T., Tsuchikawa, T., and Shichinohe, T. (2022). Retroviral Replicating Vector Toca 511 (Vocimagene Amiretrorepvec) for Prodrug Activator Gene Therapy of Lung Cancer. Cancers, 14.","DOI":"10.20944\/preprints202207.0015.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/104303403321070810","article-title":"Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors","volume":"14","author":"Wang","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chen, S.H., Sun, J.M., Chen, B.M., Lin, S.C., Chang, H.F., Collins, S., Chang, D., Wu, S.F., Lu, Y.C., and Wang, W. (2020). Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041433"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/neuonc\/noy075","article-title":"Durable complete responses in some recurrent highgrade glioma patients treated with Toca 511+Toca FC","volume":"20","author":"Cloughesy","year":"2018","journal-title":"Neuro-Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jamaoncol.2020.3161","article-title":"Effect of Vocimagene Amiretrorepvec in Combination with Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients with Recurrent High-Grade Glioma: A Randomized Clinical Trial","volume":"6","author":"Cloughesy","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Fujino, H., Sonoda-Fukuda, E., Isoda, L., Kawabe, A., Takarada, T., Kasahara, N., and Kubo, S. (2023). Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241914823"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.21873\/anticanres.16734","article-title":"Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer","volume":"43","author":"Isoda","year":"2023","journal-title":"Anticancer. Res."},{"key":"ref_28","first-page":"3","article-title":"A comprehensive review of genomic perspectives of canine diseases as a model to study human disorders","volume":"87","author":"Kaur","year":"2023","journal-title":"Can. J. Vet. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/neuonc\/nor199","article-title":"Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector","volume":"14","author":"Ostertag","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"341ra375","DOI":"10.1126\/scitranslmed.aad9784","article-title":"Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma","volume":"8","author":"Cloughesy","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ymthe.2005.03.017","article-title":"Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma","volume":"12","author":"Tai","year":"2005","journal-title":"Mol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1742-4690-8-53","article-title":"The receptors for gibbon ape leukemia virus and amphotropic murine leukemia virus are not downregulated in productively infected cells","volume":"8","author":"Liu","year":"2011","journal-title":"Retrovirology"},{"key":"ref_33","first-page":"4239","article-title":"Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection","volume":"10","author":"Miller","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/MMBR.65.3.371-389.2001","article-title":"Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins","volume":"65","author":"Overbaugh","year":"2001","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101408","DOI":"10.1016\/j.tice.2020.101408","article-title":"Establishing cell lines for canine tonsillar and non-tonsillar oral squamous cell carcinoma and identifying characteristics associated with malignancy","volume":"67","author":"Noguchi","year":"2020","journal-title":"Tissue Cell"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/5\/2657\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:04:27Z","timestamp":1760105067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/5\/2657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,24]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ijms25052657"],"URL":"https:\/\/doi.org\/10.3390\/ijms25052657","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,24]]}}}